サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1575023

バレット食道市場：タイプ別、治療法別、診断別、投与経路別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測

Barrett's Esophagus Market, By Type, By Treatment, By Diagnosis, By Route of Administration, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
バレット食道市場：タイプ別、治療法別、診断別、投与経路別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

2023年のバレット食道市場規模は63億4,098万米ドルで、2024年から2032年にかけてCAGR 5.20％で拡大

バレット食道市場-市場力学

バレット食道患者における食道がんリスクに対する認識の高まり

バレット食道患者の食道がんリスクに対する認識の高まりが市場の主要促進要因です。患者は食道腺がんとの関連を含め、バレット食道の深刻な影響について知るにつれ、検診や治療を受ける可能性が高くなります。例えば、米国がん協会の報告によると、2024年には米国で新たに約21,560人の食道がん患者が発生すると予想されており、食道がんに対する認識と早期発見が非常に重要であることが強調されています。さらに、教育プログラムにより、認知度を高めることで、高リスク群の検診率が最大50％向上することが実証されています。このような知識の増加は、患者が自分の健康を管理するために積極的な手段を講じることを促し、診断的処置や治療的介入に対する需要をさらに刺激します。その結果、Barrett食道市場は患者の関与と認知度向上への取り組みによって大きく成長するものと思われます。

バレット食道市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約5.20％のCAGRで年間成長すると予測されています。

タイプ別では、2023年には異形成なしが最大の市場シェアを示すと予測されます。

治療法別では、2023年には薬物療法が主要タイプでした。

診断別では、2023年に内視鏡検査が主要タイプでした。

投与経路別では、2023年に経口投与が主要タイプでした。

エンドユーザー別では、2023年に病院が主要タイプでした。

地域別では、北米が2023年の売上高でトップ

バレット食道市場-セグメンテーション分析：

世界のバレット食道市場は、タイプ、治療法、診断、投与経路、エンドユーザー、地域に基づいてセグメント化されます。

市場はタイプによって3つに分類される：異形成なし、低悪性度異形成、高悪性度異形成、その他。異形成なし」のセグメントが最も大きいです。多くの人がこのカテゴリーに分類され、診断件数が多くなります。これらの患者は通常、状態をモニターするために定期的な検診が必要であり、医療サービスの需要を牽引しています。治療には多くの場合、生活習慣の改善やプロトンポンプ阻害剤のような薬剤が広く使用されています。バレット食道に対する認識が高まり、定期的な検診が行われるようになったことも、バレット食道と診断される患者の増加に寄与しています。低悪性度異形成と高悪性度異形成のセグメントは、そのがんリスクにより重要であるが、異形成なしのセグメントは、その有病率と確立された治療オプションにより、依然として最も重要です。

市場は治療法に基づき2つのカテゴリーに分けられる：バレット食道の治療では、薬物療法が最も優勢です。これには、制酸剤やプロトンポンプ阻害剤（PPI）のような広く使用されている選択肢が含まれ、胃酸を減らして症状を管理するのに役立ちます。多くの患者は、特に症状が軽いか全くない場合、これらの薬に頼っています。H2ブロッカーや促進剤もこのセグメントに寄与しているが、一般的に処方されることは少ないです。バレット食道の有病率が高いということは、多くの患者が効果的な管理のために継続的な薬物療法を必要としているということです。

バレット食道市場-地理的洞察

バレット食道市場の地域情勢は特にダイナミックであり、北米が最大かつ最速の成長地域となっています。この成長は、胃食道逆流症（GERD）の有病率の高さ、バレット食道に対する認知度の向上、および先進的なヘルスケアインフラによってもたらされています。

米国では進行中の調査や臨床試験が革新的な治療法の選択肢に貢献しています。欧州もこれに続き、ドイツや英国のような国々も同様の要因により成長を遂げています。

バレット食道市場-競合情勢：

バレット食道市場の競合情勢は、医薬品、医療機器、診断など多様な主要企業が存在することが特徴です。Boehringer Ingelheim、Merck、Pfizerなどの大手製薬会社は、プロトンポンプ阻害薬や食道がんの新規治療薬など、効果的な治療法の開発に注力しています。医療機器分野では、ボストン・サイエンティフィック社やメドトロニック社などが内視鏡ツールやアブレーション技術でイノベーションを起こしています。ホロジックやオリンパスのような診断企業は、早期発見のための生検や画像診断ソリューションを進めています。しかし、規制上のハードルや償還の問題などの課題は依然として残っています。ビジネスチャンスは、認知度の向上と新規治療薬の開発にあり、戦略的提携により製品提供と市場開拓が強化されます。

目次

第1章 バレット食道市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 バレット食道の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 バレット食道産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 バレット食道市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 バレット食道市場情勢

  • バレット食道市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 バレット食道市場- タイプ別

  • 概要
    • タイプ別セグメントシェア分析
    • 異形成なし
    • 低度異形成
    • 高度異形成
    • その他

第8章 バレット食道市場-治療法別

  • 概要
    • 治療法別セグメントシェア分析
    • 薬
    • 手術
    • その他

第9章 バレット食道市場- 診断別

  • 概要
    • 診断別セグメントシェア分析
    • 内視鏡検査
    • 生検
    • その他

第10章 バレット食道市場- 投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • 経口
    • 経直腸投与
    • 非経口
    • その他

第11章 バレット食道市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • 専門クリニック
    • ホームケア
    • その他

第12章 バレット食道市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第13章 主要ベンダー分析- バレット食道業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Boston Scientific Corporation
    • Medtronic
    • Cook Medical
    • Johnson &Johnson（Ethicon）
    • Hologic, Inc.
    • Olympus Corporation
    • EndoGastric Solutions
    • PAVmed Inc.
    • Boehringer Ingelheim
    • Merck &Co.
    • Pfizer Inc.
    • Takeda Pharmaceutical Company
    • Amgen Inc.
    • AbbVie Inc.
    • Stryker Corporation
    • Baxter International Inc.
    • Intuitive Surgical, Inc.
    • GRAIL, Inc.

第14章 アナリストの全方位展望

目次
Product Code: ANV3978

REPORT HIGHLIGHT

Barrett's Esophagus Market size was valued at USD 6,340.98 million in 2023, expanding at a CAGR of 5.20% from 2024 to 2032.

Barrett's Esophagus is a condition where the tissue lining the esophagus is replaced by a different type of tissue, often due to chronic gastroesophageal reflux disease (GERD). This change can increase the risk of esophageal cancer, making early detection and management crucial. The Barrett's Esophagus market encompasses various treatment options, including medications, surgical interventions, and diagnostic tools. With rising awareness of the condition and its associated risks, the market is experiencing significant growth, particularly in regions with high GERD prevalence. Effective management strategies focus on monitoring, medication, and, in severe cases, surgical procedures to prevent complications.

Barrett's Esophagus Market- Market Dynamics

Increasing awareness of esophageal cancer risk among Barrett's patients.

Increasing awareness of esophageal cancer risk among Barrett's esophagus patients is a key driver in the market. As patients learn more about the serious implications of Barrett's esophagus, including its connection to esophageal adenocarcinoma, they are more likely to seek screening and treatment. For instance, the American Cancer Society reports that in 2024, approximately 21,560 new cases of esophageal cancer are expected in the U.S., underscoring the critical need for awareness and early detection. Moreover, educational programs have demonstrated that raising awareness can increase screening rates by up to 50% among high-risk groups. This growing knowledge empowers patients to take proactive steps in managing their health, further stimulating demand for diagnostic procedures and therapeutic interventions. As a result, the Barrett's esophagus market is poised for significant growth driven by heightened patient engagement and awareness initiatives.

Barrett's Esophagus Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.20% over the forecast period (2024-2032)

Based on Type segmentation, No Dysplasia was predicted to show maximum market share in the year 2023

Based on Treatment segmentation, Medication, was the leading type in 2023

Based on Diagnosis segmentation, Endoscopy was the leading type in 2023

Based on Route of Administration segmentation, Oral was the leading type in 2023

Based on End-user segmentation, Hospitals was the leading type in 2023

Based on Region, North America was the leading revenue generator in 2023

Barrett's Esophagus Market- Segmentation Analysis:

The Global Barrett's Esophagus Market is segmented based on Type, Treatment, Diagnosis, Route of Administration, End User, and Region.

The market is divided into three categories based on Type: No Dysplasia, Low-Grade Dysplasia, High-Grade Dysplasia, and Others. The No Dysplasia segment is the largest. Many people fall into this category, leading to a higher number of diagnoses. These patients usually need regular check-ups to monitor their condition, driving demand for medical services. Treatment often involves lifestyle changes and medications like proton pump inhibitors, which are widely used. Increased awareness about Barrett's Esophagus and routine screenings also contribute to more people being diagnosed in this group. While the low-grade and high-grade dysplasia segments are important due to their cancer risks, the no-dysplasia segment remains the most significant because of its prevalence and established treatment options.

The market is divided into two categories based on Treatment: Medication, Surgery, and Others, In the treatment of Barrett's Esophagus, the medication segment is the most dominant. This includes widely used options like antacids and proton pump inhibitors (PPIs), which help reduce stomach acid and manage symptoms. Many patients rely on these medications, especially those with mild or no symptoms. H2 blockers and promotility agents also contribute to this segment but are less commonly prescribed. The high prevalence of Barrett's Esophagus means that a large number of patients require ongoing medication for effective management

Barrett's Esophagus Market- Geographical Insights

The regional landscape of the Barrett's Esophagus market is notably dynamic, with North America emerging as the largest and fastest-growing region. This growth is driven by a high prevalence of gastroesophageal reflux disease (GERD), increased awareness of Barrett's Esophagus, and advanced healthcare infrastructure.

Ongoing research and clinical trials in the U.S. contribute to innovative treatment options. Europe follows closely, with countries like Germany and the UK also experiencing growth due to similar factors.

Barrett's Esophagus Market- Competitive Landscape:

The competitive landscape of Barrett's Esophagus market features a diverse array of key players across pharmaceuticals, medical devices, and diagnostics. Major pharmaceutical companies like Boehringer Ingelheim, Merck, and Pfizer are focused on developing effective therapies, including proton pump inhibitors and new treatments for esophageal cancer. Firms such as Boston Scientific and Medtronic are innovating with endoscopic tools and ablation technologies in the medical device sector. Diagnostic companies like Hologic and Olympus are advancing biopsy and imaging solutions for early detection. However, challenges such as regulatory hurdles and reimbursement issues persist. Opportunities lie in rising awareness and developing novel therapeutics, with strategic collaborations enhancing product offerings and market reach.

Recent Developments:

In August 2022, The American College of Gastroenterology published updated guidelines for Barrett's esophagus, recommending a broader range of screening methods beyond just endoscopy, more frequent surveillance for short-segment Barrett's esophagus, and the establishment of volume criteria for centers performing endoscopic therapies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BARRETT'S ESOPHAGUS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Boston Scientific Corporation
  • Medtronic
  • Cook Medical
  • Johnson & Johnson (Ethicon)
  • Hologic, Inc.
  • Olympus Corporation
  • EndoGastric Solutions
  • PAVmed Inc.
  • Boehringer Ingelheim
  • Merck & Co.
  • Pfizer Inc.
  • Takeda Pharmaceutical Company
  • Amgen Inc.
  • AbbVie Inc.
  • Stryker Corporation
  • Baxter International Inc.
  • Intuitive Surgical, Inc.
  • GRAIL, Inc.

GLOBAL BARRETT'S ESOPHAGUS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • No Dysplasia
  • Low-Grade Dysplasia
  • High-Grade Dysplasia
  • Others

GLOBAL BARRETT'S ESOPHAGUS MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

  • Medication
  • Surgery
  • Others

GLOBAL BARRETT'S ESOPHAGUS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

  • Endoscopy
  • Biopsy
  • Others

GLOBAL BARRETT'S ESOPHAGUS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Rectal
  • Parenteral
  • Others

GLOBAL BARRETT'S ESOPHAGUS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

GLOBAL BARRETT'S ESOPHAGUS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Barrett's Esophagus Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Barrett's Esophagus Market Snippet by Type
    • 2.1.2. Barrett's Esophagus Market Snippet by Treatment
    • 2.1.3. Barrett's Esophagus Market Snippet by Diagnosis
    • 2.1.4. Barrett's Esophagus Market Snippet by Route of Administration
    • 2.1.5. Barrett's Esophagus Market Snippet by End User
    • 2.1.6. Barrett's Esophagus Market Snippet by Country
    • 2.1.7. Barrett's Esophagus Market Snippet by Region
  • 2.2. Competitive Insights

3. Barrett's Esophagus Key Market Trends

  • 3.1. Barrett's Esophagus Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Barrett's Esophagus Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Barrett's Esophagus Market Opportunities
  • 3.4. Barrett's Esophagus Market Future Trends

4. Barrett's Esophagus Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Barrett's Esophagus Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Barrett's Esophagus Market Landscape

  • 6.1. Barrett's Esophagus Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Barrett's Esophagus Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. No Dysplasia
    • 7.1.3. Low-Grade Dysplasia
    • 7.1.4. High-Grade Dysplasia
    • 7.1.5. Others

8. Barrett's Esophagus Market - By Treatment

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 8.1.2. Medication
    • 8.1.3. Surgery
    • 8.1.4. Others

9. Barrett's Esophagus Market - By Diagnosis

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
    • 9.1.2. Endoscopy
    • 9.1.3. Biopsy
    • 9.1.4. Others

10. Barrett's Esophagus Market - By Route of Administration

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 10.1.2. Oral
    • 10.1.3. Rectal
    • 10.1.4. Parenteral
    • 10.1.5. Others

11. Barrett's Esophagus Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Specialty Clinics
    • 11.1.4. Homecare
    • 11.1.5. Others

12. Barrett's Esophagus Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Barrett's Esophagus Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Barrett's Esophagus Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Barrett's Esophagus Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Barrett's Esophagus Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Barrett's Esophagus Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Barrett's Esophagus Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. Boston Scientific Corporation
    • 13.2.2. Medtronic
    • 13.2.3. Cook Medical
    • 13.2.4. Johnson & Johnson (Ethicon)
    • 13.2.5. Hologic, Inc.
    • 13.2.6. Olympus Corporation
    • 13.2.7. EndoGastric Solutions
    • 13.2.8. PAVmed Inc.
    • 13.2.9. Boehringer Ingelheim
    • 13.2.10. Merck & Co.
    • 13.2.11. Pfizer Inc.
    • 13.2.12. Takeda Pharmaceutical Company
    • 13.2.13. Amgen Inc.
    • 13.2.14. AbbVie Inc.
    • 13.2.15. Stryker Corporation
    • 13.2.16. Baxter International Inc.
    • 13.2.17. Intuitive Surgical, Inc.
    • 13.2.18. GRAIL, Inc.

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us